Lymphadenopathy diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:


==Diagnostic Criteria==
==Diagnostic Criteria==
Diagnostic criteria is the gold standard test for the diagnosis of lymphadenopathy.
Diagnostic criteria could help for the diagnosis of lymphadenopathy.
====Malignant Lymphadenopathy====  
====Malignant Lymphadenopathy====  
:*Node > 2 cm
:*Node > 2 cm
Line 21: Line 21:
:*No associated risk factors  
:*No associated risk factors  
:*Palpable and painful enlargement
:*Palpable and painful enlargement


==References==
==References==

Revision as of 14:25, 25 March 2021

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy diagnostic criteria

CDC on Lymphadenopathy diagnostic criteria

Lymphadenopathy diagnostic criteria in the news

Blogs on Lymphadenopathy diagnostic criteria

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]Delband Yekta Moazami, M.D.[3]

Overview

Diagnostic criteria for malignant lymphadenopathy may include: the size of node more than 2 cm, a node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever, and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy may include: node smaller than 1 cm, a node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement.[1][2]

Diagnostic Criteria

Diagnostic criteria could help for the diagnosis of lymphadenopathy.

Malignant Lymphadenopathy

Benign Lymphadenopathy

  • Node < 1 cm
  • Node that is mobile, soft-or tender, and is not fixed to underlying tissue
  • Common location (e.g. supraclavicular node)
  • No associated risk factors
  • Palpable and painful enlargement

References

  1. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  2. Ferrer R (October 1998). "Lymphadenopathy: differential diagnosis and evaluation". Am Fam Physician. 58 (6): 1313–20. PMID 9803196.

Template:WH Template:WS